BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16285732)

  • 1. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
    Prince T; Sun L; Matts RL
    Biochemistry; 2005 Nov; 44(46):15287-95. PubMed ID: 16285732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
    Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
    Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients.
    Scroggins BT; Prince T; Shao J; Uma S; Huang W; Guo Y; Yun BG; Hedman K; Matts RL; Hartson SD
    Biochemistry; 2003 Nov; 42(43):12550-61. PubMed ID: 14580201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A client-binding site of Cdc37.
    Terasawa K; Minami Y
    FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
    Yun BG; Matts RL
    Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
    Roiniotis J; Masendycz P; Ho S; Scholz GM
    Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
    Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
    J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.
    Shao J; Grammatikakis N; Scroggins BT; Uma S; Huang W; Chen JJ; Hartson SD; Matts RL
    J Biol Chem; 2001 Jan; 276(1):206-14. PubMed ID: 11036079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc37 maintains cellular viability in Schizosaccharomyces pombe independently of interactions with heat-shock protein 90.
    Turnbull EL; Martin IV; Fantes PA
    FEBS J; 2005 Aug; 272(16):4129-40. PubMed ID: 16098195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
    Yun BG; Matts RL
    Cell Signal; 2005 Dec; 17(12):1477-85. PubMed ID: 15935620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding.
    Shao J; Irwin A; Hartson SD; Matts RL
    Biochemistry; 2003 Nov; 42(43):12577-88. PubMed ID: 14580204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates.
    Hartson SD; Thulasiraman V; Huang W; Whitesell L; Matts RL
    Biochemistry; 1999 Mar; 38(12):3837-49. PubMed ID: 10090774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37.
    Prince T; Matts RL
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1447-54. PubMed ID: 16269130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions.
    Yun BG; Huang W; Leach N; Hartson SD; Matts RL
    Biochemistry; 2004 Jun; 43(25):8217-29. PubMed ID: 15209518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37.
    Prince T; Matts RL
    J Biol Chem; 2004 Sep; 279(38):39975-81. PubMed ID: 15258137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
    Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
    J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
    Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
    Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
    Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
    Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Cdc37 and Cdk4 in human cells.
    Lamphere L; Fiore F; Xu X; Brizuela L; Keezer S; Sardet C; Draetta GF; Gyuris J
    Oncogene; 1997 Apr; 14(16):1999-2004. PubMed ID: 9150368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.